摘要
目的:制备两株抗人心肌肌钙蛋白Ⅰ(human cardiac troponinⅠ,cTnⅠ)单克隆抗体,建立鲁米诺化学发光酶免疫分析法。方法:制备腹水型单抗、饱和硫酸铵沉淀法和亲和层析柱Protein G纯化抗体,并通过SDS-PAGE和ELISA对抗体特异性进行鉴定,建立鲁米诺化学发光酶免疫分析法,并对30份临床血清样本进行检测。结果:本实验制备的两株单抗(分别命名为Ab1、Ab3;亚型都是Ig G1)能够识别以cTnⅠ单体、cTnⅠ-C复合物和cTnⅠ-T-C复合物不同形式存在的cTnⅠ。Ab1、Ab3的效价分别为1∶80万和1∶40万,亲和力常数分别为1.62×109L/mol、2.60×108L/mol。利用2株单抗建立的鲁米诺化学发光酶免疫分析法检测范围为:6.25~400 ng/ml。对30份临床样本进行检测,阳性检出率为77.3%,阴性检出率为100%。结论:建立了可以检测以cTnⅠ单体、cTnⅠ-C和cTnⅠ-T-C复合物形式存在的cTnⅠ的鲁米诺化学发光酶免疫分析法,具有更高的实用性。
Objective: Two anti-human cardiac troponin I( cTnⅠ) monoclonal antibodies were prepared to establish Luminol chemiluminescence enzyme immunoassay. Methods: Obtaining ascites monoclonal antibody was purified by ammonium sulfate fractionation and protein G affinity chromatography column,and their specificity was identified by SDS-PAGE and ELISA methods. Luminol chemiluminescence enzyme immunoassay was successfully established,which was used to detect 30 clinical serum samples. Results:Two antibodies named Ab1 and Ab3 could recognize different forms of cTnⅠ including cTnⅠ monomers,cTnⅠ-C complexes and cTnⅠ-T-C complexes. Both Ab1 and Ab3 are Ig G1. The titers of the Ab1 and the Ab3 were up to 1 ∶800 000 and 1 ∶400 000,respectively. The affinity constants of Ab1 and Ab3 were 1. 62 × 109 L/mol and 2. 60 × 108 L/mol,respectively. The detection range of Lumino chemiluminescence enzyme immunoassay established by two monoclonal antibodies was 6. 25 ng/ml to 400 ng/ml. Detecting 30 clinical samples attained the positive detection rate of 77. 3% and the negative detection rate of 100%. Conclusion: The chemilu minescence enzyme immunoassay has been established to detect different forms of cTnⅠ including cTnⅠ monomer,cTnⅠ-C complexes and cTnⅠ-T-C complexes,which has better practicality.
作者
李文丽
余鹃
向军俭
王宏
LI Wen-Li;YU-Juan;XIANG Jun-Jian;WANG Hong(Department of Bioengineering, School of Life Science and Technology, Jinan University, Guangzhou 510632, China)
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
2018年第5期712-717,共6页
Chinese Journal of Immunology
基金
广东省核心技术攻关项目"免疫荧光定量快速检测诊断"(2012A080800007)